Apellis Pharmaceuticals, Inc.
APLS
Revenue
178.49M
▲11.70M▲7.01%
3 Months ChangeAssets
821.39M
▲14.11M▲1.75%
3 Months ChangeLiabilities
665.09M
▲22.02M▲3.42%
3 Months ChangeFree Cash Flow
-53.42M
▲79.86M▲59.92%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-08
Form 8-K
ID: 0001193125-24-196465
2024-08-01
Form 10-Q
ID: 0000950170-24-088938
2024-06-05
Form 8-K
ID: 0001193125-24-155179
2024-05-14
Form 8-K
ID: 0001193125-24-137743
2024-05-07
Form 10-Q
ID: 0000950170-24-053921
2024-02-27
Form 8-K
ID: 0001193125-24-047073
2024-01-22
Form 8-K
ID: 0001193125-24-011699
2024-01-08
Form 8-K
ID: 0001193125-24-003998
2023-12-14
Form 8-K
ID: 0001193125-23-294892
2023-12-01
Form 8-K
ID: 0001193125-23-286826